Trial of intravenous novocaine treatment for visual disturbances caused by trypanocidal arsenicals.
D000563:Amebicides; D000779:Anesthetics, Local / Q000628:therapy*; D000981:Antiprotozoal Agents; D000994:Antitrichomonal Agents; D001151:Arsenic / Q000633:toxicity*; D020261:Arsenic Poisoning; D006233:Persons with Disabilities; D011343:Procaine / Q000031:analogs & derivatives; D014785:Vision, Ocular
D000563:Amebicides; D000779:Anesthetics, Local; D000981:Antiprotozoal Agents; D000994:Antitrichomonal Agents; D011343:Procaine; D001151:Arsenic
ARSENIC AND ARSENIC COMPOUNDS/toxicity; PROCAINE AND PROCAINE COMPOUNDS/therapy; VISION/defective
Essai de traitement par la novocaïne intraveineuse des troubles visuels causés par les arsenicaux trypanocides.